Clinical and genetic associations with hypertriglyceridemic waist in a Canadian aboriginal population

International Journal of Obesity

Volumn 30, Issue 3, 2006, Pages 484-491

  Pollex, R L ^a   Hanley, A J G ^b   Zinman, B ^b   Harris, S B ^c   Hegele, R A ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cross sectional study; Genetics; Hypertriglyceridemic waist; North American aboriginal population; Risk factors; Type 2 diabetes

Indexed keywords

ANGIOTENSINOGEN; APOLIPOPROTEIN C3; FATTY ACID BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; NUCLEAR FACTOR I; NUCLEOTIDE; PHOSPHOPROTEIN PHOSPHATASE 1;

3' UNTRANSLATED REGION; ABORIGINE; ANTHROPOMETRY; ARTICLE; CANADA; CODON; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENDER; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PLASMA; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ABDOMINAL FAT; ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; BODY CONSTITUTION; CANADA; CHILD; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGIC METHODS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; HYPERTRIGLYCERIDEMIA; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; MUTATION; SEX FACTORS;

EID: 33644623295     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803152     Document Type: Article

References (35)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486-2497.
2. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156: 1070-1077.
3. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
4. Lamarche B, Tchernof A, Mauriege P, Cantin B, Dagenais GR, Lupien PJ et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998; 279: 1955-1961.
5. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000; 102: 179-184.
6. Bell D, McAuley KA, Mann J, Murphy L, Williams S. The hypertriglyceridaemic waist in New Zealand Maori. Asia Pac J Clin Nutr 2004; 13: 74-77.
7. LaMonte MJ, Ainsworth BL, DuBose KD, Grandjean PW, Davis PG, Yanowitz FG et al. The hypertriglyceridemic waist phenotype among women. Atherosclerosis 2003; 171: 123-130.
8. Lemieux I, Aimeras N, Mauriege P, Blanchet C, Dewailly L, Bergeron J et al. Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol 2002; 18: 725-732.
9. Bos G, Dekker JM, Heine RJ. Non-HDL cholesterol contributes to the 'hypertriglyceridemic waist' as a cardiovascular risk factor: the Hoorn study. Diabetes Care 2004; 27: 283-284.
10. Young TK, Reading J, Elias B, O'Neil JD. Type 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress. CMAJ 2000; 163: 561-566.
11. Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM, Gao J et al. The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care 1997; 20: 185-187.
12. Hegele RA, Cao H, Harris SB, Hanley AJ, Zinman B. The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab 1999; 84: 1077-1082.
13. Triggs-Raine BL, Kirkpatrick RD, Kelly SL, Norquay LD, Cattini PA, Yamagata K et al. HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proc Natl Acad Sci USA 2002; 99: 4614-4619.
14. Gittelsohn J, Wolever TM, Harris SB, Harris-Giraldo R, Hanley AJ, Zinman B. Specific patterns of food consumption and preparation are associated with diabetes and obesity in a Native Canadian community. J Nutr 1998; 128: 541-547.
15. Kriska AM, Hanley AJ, Harris SB, Zinman B. Physical activity, physical fitness, and insulin and glucose concentrations in an isolated Native Canadian population experiencing rapid lifestyle change. Diabetes Care 2001; 24: 1787-1792.
16. Shah BR, Hux JE, Zinman B. Increasing rates of ischemic heart disease in the native population of Ontario, Canada. Arch Intern Med 2000; 160: 1862-1866.
17. Pollex RL, Hanley AJG, Zinman B, Harris SB, Khan HMR, Hegele R. Synergism between mutant HNF1A and the metabolic syndrome in Oji-Cree type 2 diabetes. Diabet Med 2005; 22: 1510-1515.
18. Pollex RL, Hanley AJG, Zinman B, Harris SB, Khan HMR, Hegele R. Metabolic syndrome in aboriginal Canadians: prevalence and genetic associations. Atherosclerosis 2005 (in press) [Epub ahead of print] PMID: 15869758.
19. Hanley AJG, Harris SB, Barnie A, Gittelsohn J, Wolever TMS, Logan A et al. The Sandy Lake Health and Diabetes Project: design, methods and lessons learned. Chronic Dis Canada 1995; 16: 149-156.
20. Hanley AJ, Harris SB, Gao XJ, Kwan J, Zinman B. Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM. Diabetes Care 1997; 20: 1408-1415.
21. Hegele RA, Harris SB, Hanley AJ, Sun F, Connelly PW, Zinman B. Angiotensinogen gene variation associated with variation in blood pressure in aboriginal Canadians. Hypertension 1997; 29: 1073-1077.
22. Hegele RA, Harris SB, Hanley AJ, Cao H, Zinman B. G protein beta3 subunit gene variant and blood pressure variation in Canadian Oji-Cree. Hypertension 1998; 32: 688-692.
23. Hegele RA, Harris SB, Hanley AJ, Sadikian S, Connelly PW, Zinman B. Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J Clin Endocrinol Metab 1996; 81: 4334-4337.
24. Hegele RA, Connelly PW, Hanley AJ, Sun F, Harris SB, Zinman B. Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins. Arterioscler Thromb Vasc Biol 1997; 17: 2753-2758.
25. Hegele RA, Harris SB, Zinman B, Wang J, Cao H, Hanley AJ et al. Variation in the AU(AT)-rich element within the 3′-untranslated region of PPP1R3 is associated with variation in plasma glucose in aboriginal Canadians. J Clin Endocrinol Metab 1998; 83: 3980-3983.
26. Hill WG, Robertson A. Linkage disequilibrium in finite populations. Theor Appl Genet 1968; 38: 226-231.
27. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Despres JP. A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr 1996; 64: 685-693.
28. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952.
29. Jemaa R, Tuzet S, Portos C, Betoulle D, Apfelbaum M, Fumeron F. Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int J Obes Relat Metab Disord 1995; 19: 270-274.
30. Baier LJ, Bogardus C, Sacchettini JC. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 1996; 271: 10892-10896.
31. Baier EJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995; 95: 1281-1287.
32. Hegele RA, Connelly PW, Hanley AJ, Sun F, Harris SB, Zinman B. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. Arterioscler Thromb Vasc Biol 1997; 17: 1060-1066.
33. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998; 18: 45-48.
34. Siffert W, Forster P, Jockel KH, Mvere DA, Brinkmann B, Naber C et al. Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 1999; 10: 1921-1930.
35. Yamamoto M, Abe M, Jin JJ, Wu Z, Tabara Y, Mogi M et al. Association of GNB3 gene with pulse pressure and clustering of risk factors for cardiovascular disease in Japanese. Biochem Biophys Res Commun 2004; 316: 744-748.